Lessons from experimental APS models

Lupus

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Shoenfeld, Y ^a   Ziporen, L ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti cardiolipin; Anti phospholipid syndrome; Autoimmunity; Thrombocytopenia; 2 GPI

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; BEHAVIOR; CONFERENCE PAPER; FETUS OUTCOME; FETUS WASTAGE; HISTOLOGY; KIDNEY FAILURE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENICITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCID MOUSE; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOSIS;

EID: 0031790330     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339800700234     Document Type: Conference Paper

References (47)

1. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancer 1993; 342. 341-344.
2. Asherson RA, Cervera R, Piette JC, and Shoenfeld Y. The antiphospholipid syndrome. CRC Press: Boca Raton, Fl. 1996.
3. Asherson R. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19; 508-512.
4. Bruyn, GAW. Controversies in lupus, nervous system involvement. Ann Rheum Dis 1995; 54: 159-167.
5. Lie IT. vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 1989, 16: 713-715.
6. Lie JT. Vasculitis in the antiphospholipid syndiome' culprit or consort? J Rheumatol 1994; 21: 397-399.
7. Cervera R, Asherson RA, Lie JT Clinicopathological correlation of the antiphospholipid syndrome. Semin Arthritis Rheum 1995, 24: 262-272
8. Ziporen L, Blank M, Shoenfeld Y Animal models for APS in pregnancy. Rheum Dis Clin North Am 1997, 23(1): 99-117.
9. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies Proc Natl Acad Sci USA 1991; 88: 3069-3073.
10. Blank M, Tincani A, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with purified IgG anti-phosphatidylserine antibodies. J Rheumatol 1994; 21: 100-104.
11. Branch WD et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss Am J Obstet Gynecol 1990; 163, 210-216.
12. Silver RM et al Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997, 176: 628-633.
13. Vogt E, Ng AK, Rote NS. A model for the antiphospholipid antibody syndrome' monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996; 174: 700-707.
14. Suzuki T et al Effects of monoclonal anticardiolipin antibodies on pregnant mice. J Rheumatol 1996, 23: 83-86.
15. Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental APS lessons from murinc models. Lupus 1996; 5: 458-462.
16. Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993, 90: 6464-6467.
17. Ziporen L et al. Libman-Sacks endocarditis in the antimiphospholipid syndrome' Immunopathologic findings in deformed heart valves. Lupus 1996; 5: 196-205.
18. Hojnik M, George J, Ziporen L, Shoenfeld Y Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome Circulation 1996; 93: 1579-1587.
19. Levine, SR, Deegan MJ, Futreu N, Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990, 40: 1181-1189
20. Brey RL, Gharavi AE, Lockshin MD Neurologic complications of antiphospholipid antibodies. Rheum Dis Clin. North Am. 1993; 19. 833-850
21. Westerman EM. Miles JM, Backonja M, Sundstrom WR Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Arthritis Rheum 1992, 35: 1038-1041
22. Verrot D et al Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 1997; 103: 33-37.
23. Cervera R et al. Chorea in the antiphospholipid syndrome Clinical, radiological, and immunologic characteristic of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997; 76: 203-212.
24. Inzelberg R, Bornstein NM, Reider I, Korezyn AD. The lupus anticoagulant and dementia in non-SLE patients. Dementia 1992; 3; 140-145.
25. Kent M et al. Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 1997; 24. 1725-1733
26. Caronti B, Pittoni V, Palladini G, Valesini G. Anti-β 2 glycoprotein I antibodies bind to central nervous system. J Neurol Sciene (in press).
27. Sun KH et al. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann. Rheum. Dis. 1992; 51: 707-712.
28. Liou HH et al. Anticardiolipin antisera from lupus patients with seizure reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci 1994, 54: l119-1125.
29. Hess DC et al. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J. Rheumatol 1993; 20: 610-617.
30. Brey RL et al. Model for the neuromuscular complications of systemic lupus erythematosus Lupus 1995; 4: 209-212.
31. Brey RL, Cote SA, Teale JM. Autoimmune disease is accelerated in MRL/ + + mice after apulipoprotein H immunization. Neurology 1994, 44 (Suppl. 2): A316 (abstr).
32. Ziporen L, Shoenfeld Y, Levy Y, Korzcyn AD Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies a mouse model. The Journal of Clinical Investigation 1997: 100(3) 613-619
33. Bakimer R et al. Induction of primary antiphospholipid syndrome in mice by immunizing with a human monoclonal anticardiolipin antibodies(H3). J Clin Invest 1992; 89: 1558-1563.
34. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994; 8: 1296-1301.
35. Ziporen L et al. Neurological dysfunction associated with APS in animal model pathological findings Lupus 1998, 7 (Suppl. 1) (abstr.).
36. Smith HR, Hansen CL, Rose R, Canoso RT. Autoimmune MRL-lpr/lpr mice are an animal model for the secondary antiphospholipid syndrome. J Rheumatol 1990; 17: 911-915.
37. Vogelweid CM et al. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice comparative histologic and immunohistochemical findings. J Neuroimmunol 1991; 35: 89-99.
38. Ziporen L, Korczyn AD, Kariv N, Shoenfeld Y. Cognitive impairments are associated with elevated levels of anti-phospholipid antibodies in rats. Lupus 1998, (Suppl, 1) (abstr.).
39. 2glycoprotein 1 (apolipoprotein H) J Clin Invest 1992, 90: 1105-1109.
40. Blank M et al. Immunization by cofactor (beta-2-glycoprotein) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7: 441-455.
41. Aron AL et al. Early onset of autoimmunity in MRL/ + + mice following immunization with β2 glycoprotein. Clin Exp Immunol 1995; 101: 78-81.
42. Garcia CO et al. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta-2-GPI. Am J Reprod Immunol 1997: 37: 118-124
43. Kant KS et al. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 1981; 60: 71-86.
44. Asherson RA, Kant KS Antiphospholipid antibodies and the kidney. J Rheumatol 1993, 20: 1268
45. Levy Y et al Massive proteinuria as a main manifestation of primary antiphospholipid syndrome Pathobiology (in press).
46. Levy Y et al. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antibodies Hybridoma 1996; 7: 91-96
47. Pierangeli S et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1995; 71: 670-674.